MEK inhibition abrogates sunitinib resistance in a renal cell carcinoma patient-derived xenograft model.
MEK inhibition abrogates sunitinib resistance in a renal cell carcinoma patient-derived xenograft model.
复制标题
DOI：
10.1038/bjc.2016.263
复制
发表时间：
2016-10-11
影响因子：
8.8
通讯作者：
Lindner, Daniel J.
中科院分区：
文献类型：
--
作者：
Diaz-Montero, C. Marcela;Mao, Frances J.;Barnard, John;Parker, Yvonne;Zamanian-Daryoush, Maryam;Pink, John J.;Finke, James H.;Rini, Brian I.;Lindner, Daniel J.
关键词：
Renal cell carcinoma (RCC) patients treated with tyrosine kinase inhibitors (TKI) typically respond initially, but usually develop resistance to therapy. We utilised transcriptome analysis to identify gene expression changes during development of sunitinib resistance in a RCC patient-derived xenograft (PDX) model. RCC tumours were harvested during pre-treatment, response and escape phases. Direct anti-proliferative effects of sunitinib plus MEK inhibitor were assessed. Activation status (phosphorylation) of MEK1/2 and ERK1/2 was determined, myeloid-derived suppressor cells (MDSC) sub-fractions were quantitated and G-CSF was measured by ELISA. During the response phase, tumours exhibited 91% reduction in volume, characterised by decreased expression of cell survival genes. After 4-week treatment, tumours developed resistance to sunitinib, associated with increased expression of pro-angiogenic and cell survival genes. During tumour escape, cellular movement, inflammatory response and immune cell trafficking genes were induced, along with intra-tumoural accumulation of MDSC. In this PDX model, either continuous treatment with sunitinib plus MEK inhibitor PD-0325901, or switching from sunitinib to PD-0325901 was effective. The combination of PD-0325901 with TKI suppressed intra-tumoural phospho-MEK1/2, phospho-ERK1/2 and MDSC. Continuous treatment with sunitinib alone did not maintain anti-tumour response; addition of MEK inhibitor abrogated resistance, leading to improved anti-tumour efficacy.
登录
查看更多内容
影响因子：
64.5
作者：
Fischer, Christian;Jonckx, Bart;Carmeliet, Peter
通讯作者：
Carmeliet, Peter
影响因子：
50.3
作者：
Casanovas, O;Hicklin, DJ;Hanahan, D
通讯作者：
Hanahan, D
影响因子：
9.8
作者：
Gotink, Kristy J.;Verheul, Henk M. W.
通讯作者：
Verheul, Henk M. W.
影响因子：
11.2
作者：
Huang D;Ding Y;Zhou M;Rini BI;Petillo D;Qian CN;Kahnoski R;Futreal PA;Furge KA;Teh BT
通讯作者：
Teh BT
影响因子：
5.7
作者：
Bridgeman, Victoria L.;Wan, Elaine;Reynolds, Andrew R.
通讯作者：
Reynolds, Andrew R.